Gnca stock float

Low-Float Du Jour: Genocea Biosciences (NASDAQ:GNCA ... May 31, 2019 · The stock traded higher by 60 percent at $7.13 per share Friday morning. This week's trader obsession with the low-float momentum names is … GNCA - Research and Analysis for GENOCEA BIOSCIENCES, INC ...

Genocea Biosciences Percent of Float Short | GNCA View Percent of Float Short for GNCA Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Genocea Biosciences Inc Stock Quote: GNCA Stock News ... Nov 05, 2019 · GNCA, Genocea Biosciences Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines GNCA stock news - StockInvest.us Investors need to pay close attention to Genocea Biosciences (GNCA) stock based on the movements in the options market lately. Read more. Low-Float Du Jour: …

Stocktwits - The largest community for investors and traders

The Complete List of Biotech Stocks Trading on the NASDAQ as of April 6, 2020 are listed below: Note: If you are 282, Genocea Biosciences, Inc. GNCA. Gavins Felicity - March 31, 2020 0. Markets continue their float higher as selling pressure seems to be waning. Volatility is finally starting to make a meaningful  Such purchases will reduce the available public float of our common stock board of directors of Genocea Biosciences (Nasdaq:GNCA) since February 2018,   Feb 14, 2020 Compared to the average trading volume of RTN shares, the company saw a far better performance. Moreover, the stock has a 278.07M float  Please visit our buy page for more information about our US stocks and ETFs, Futures 2595, GNCA, 2/5/2014, 11, GENOCEA BIOSCIENCES, INC. Security Brokers, Dealers, and Flotation Companies, Finance, Insurance, and Real Estate.

What's going on at Genocea Biosciences (NASDAQ:GNCA)? View breaking news headlines for GNCA stock from trusted media outlets at MarketBeat.

MCOA vs. GNCA Stock Research Comparison

GNCA: Genocea Biosciences, Inc. - Brokerage ...

GNCA Stock News - Fidelity

Genocea Biosciences, Inc (GNCA) Stock Message Board ...

Avg Vol (3 month) 3, 280.32k. Avg Vol (10 day) 3, 109.99k. Shares Outstanding 5, 26.15M. Float, 13.84M. % Held by Insiders 1, 12.35%. % Held by Institutions 1  Percent of Float. 2.20% ?

Sep 26, 2017 Genocea's stock fell more than 50% in after-hours trading following the news. Concerns include the implications for Genocea's chances of  GNCA Genocea Biosciences, Inc. Stock Quote Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, to profile patient's CD4+ and CD8+ T cell immune responses to potential target or antigen in that patient's tumor. Genocea Biosciences, Inc. (GNCA) Stock Price, Quote ... Find the latest Genocea Biosciences, Inc. (GNCA) stock quote, history, news and other vital information to help you with your stock trading and investing. GNCA Stock Price | Genocea Biosciences Inc. Stock Quote (U ...